MedPath

An exploratory study of NS-304

Phase 2
Completed
Conditions
Pulmonary arterial hypertension
Registration Number
JPRN-jRCT2080225295
Lead Sponsor
ippon Shinyaku Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
6
Inclusion Criteria

Patients with PAH diagnosis confirmed by right heart catheterization

Exclusion Criteria

Patients with severe or moderate hepatic impairment etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath